BE601851A - Vaccin antipoliomyélitique et sa préparation - Google Patents

Vaccin antipoliomyélitique et sa préparation

Info

Publication number
BE601851A
BE601851A BE601851A BE601851A BE601851A BE 601851 A BE601851 A BE 601851A BE 601851 A BE601851 A BE 601851A BE 601851 A BE601851 A BE 601851A BE 601851 A BE601851 A BE 601851A
Authority
BE
Belgium
Prior art keywords
preparation
poliomyelitis vaccine
poliomyelitis
vaccine
Prior art date
Application number
BE601851A
Other languages
English (en)
Inventor
Lee Frank Schuchardt
Samuel Morton Zulick
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BE601851A publication Critical patent/BE601851A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE601851A 1960-03-30 1961-03-27 Vaccin antipoliomyélitique et sa préparation BE601851A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18500A US3097142A (en) 1960-03-30 1960-03-30 Benzyl alcohol stabilized polio vaccines and production thereof

Publications (1)

Publication Number Publication Date
BE601851A true BE601851A (fr) 1961-09-27

Family

ID=21788244

Family Applications (1)

Application Number Title Priority Date Filing Date
BE601851A BE601851A (fr) 1960-03-30 1961-03-27 Vaccin antipoliomyélitique et sa préparation

Country Status (5)

Country Link
US (1) US3097142A (fr)
BE (1) BE601851A (fr)
ES (1) ES266270A1 (fr)
FR (1) FR1265M (fr)
GB (1) GB949400A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154900B (de) * 1961-10-10 1963-09-26 Behringwerke Ag Verfahren zur Herstellung einer Poliomyelitisvaccine
WO1991002543A1 (fr) * 1989-08-15 1991-03-07 Massachusetts Institute Of Technology Compositions de vaccin stabilisees
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR885966A (fr) * 1941-10-07 1943-09-30 Ig Farbenindustrie Ag Agents désinfectants
US2793160A (en) * 1955-05-09 1957-05-21 Parke Davis & Co Poliomyelitis vaccine

Also Published As

Publication number Publication date
GB949400A (en) 1964-02-12
US3097142A (en) 1963-07-09
FR1265M (fr) 1962-06-24
ES266270A1 (es) 1961-07-01

Similar Documents

Publication Publication Date Title
BE607398A (fr) Nouvelles pyrazolones et leur préparation
FR1271180A (fr) Cyclododécylguanidine et ses dérivés et leur préparation
BE601851A (fr) Vaccin antipoliomyélitique et sa préparation
BE601852A (fr) Vaccin antipoliomyélitique et sa préparation
BE611000A (fr) Dérivés de benzazocines et leur préparation
BE613545A (fr) Aminoéthanes substitués et leur préparation
BE610695A (fr) N-(dialkylène-imido)-phosphonyl-urées et leur préparation
BE602732A (fr) Reproductions permanentes et leur préparation
FR1445453A (fr) Phénylcyclopropyl-amides et leur préparation
FR1302943A (fr) Benzylguanidines et leur préparation
FR1300734A (fr) Phényl-thiopurines et leur préparation
BE605895A (fr) Nouvelles dibenzo-diazépines et dibenzo-diazocines et leur préparation
BE603114A (fr) Nouveaux dérivés des dialkylxanthines et leur préparation
BE612024A (fr) Nouveau dérivé stérolique et sa préparation
BE595850A (fr) Nouvelles diamines disubstituées et leur préparation
FR1264017A (fr) Oxazinidinones et leur préparation
FR1300720A (fr) 2-aryl-pyrrolines et 2-aryl-tétrahydropyridines et leur préparation
FR1298332A (fr) Benzène-disulfamides et leur préparation
BE598854A (fr) 4-hydroxy-grisanes et leur préparation
FR84751E (fr) Acide cycloundécène-1 carboxylique-1 et sa préparation
FR1302939A (fr) Thiosemicarbazones et leur préparation
BE590139A (fr) 2-isopropyl-crotonyl-urée et sa préparation.
FR1294115A (fr) Dérivés du thiaxanthène et leur préparation
FR1472911A (fr) 4-méthyl-6-isobutényl-pyrone-(2) et sa préparation
BE602326A (fr) Dérivés du thiophénicol et leur préparation